Utility of brain natriuritic peptide as a diagnostic tool for congestive heart failure in the elderly

Critical Pathways in Cardiology

Volumn 4, Issue 3, 2005, Pages 140-144

  Parab, Reshma ^a,b   Vasudevan, Abu ^a   Brensilver, Jeffrey ^a   Gitler, Bernard ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

B type natriuretic peptide; Congestive heart failure; Elderly; Pneumonia

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DIAGNOSTIC TEST; DYSPNEA; ELDERLY CARE; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 24944537061     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000174912.89563.ba     Document Type: Article

References (17)

1. American Heart Association, Heart disease and stroke statistics, 2004 update. Available at www.americanheart.org.
2. Rich MW. Epidemiology, pathophysiology and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968-974.
3. McKinnon ME, McKee CM. Heart failure. The Cinderella of cardiology? Public Health. 1996;110:351-355.
4. Andrews J, Nadjm B, Gant V, et al. Community acquired pneumonia. Curr Opin Pulm Med. 2003;9:175-180.
5. Merchant S, Mullins CD, Shih YT. Factors associated with hospitalization costs for patients with community acquired pneumonia. Clin Ther. 2003;25:593-610.
6. Ramirez JA. Community acquired pneumonia in adults. Prim Care. 2003;30:155-171.
7. Shapiro BP, Chen HH, Burnett JC, et al. Use of plasma BNP concentration to aid in the diagnosis of heart failure. Mayo Clin Proc. 2003;78:481-486.
8. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 1994;343:440-444.
9. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349-1353.
10. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol. 2001;37:379-385.
11. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
12. McCullough PA, Nowak RM, McCord J, et al. B type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416-422.
13. Redfield MM, Rodeheffer RJ, Jacobson SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-982.
14. Knudsen CW, Omland T, Clopton P, et al. Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med. 2004;116:363-368.
15. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study patients. Circulation. 1993;88:107-115.
16. Mcgeer A, Campbell B, Emori TG, et al. Definitions of Infections for surveillance in long term facilities. Am J Infect Control. 1991;19:1-7.
17. Altman DG. Practical Statistics for Medical Research. Boca Rotan, FL: Chapman and Hall/CRC; 1990.